Efficacy of Upfront and Maintenance Obinutuzumab in Mantle Cell Lymphoma Treated by DHAP and MRD Driven Maintenance
Clinical trial NCT02896582 · COMPLETED
Trial details
- NCT number
- NCT02896582
- Sponsor
- The Lymphoma Academic Research Organisation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-29
- Primary completion
- 2019-03-01
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.